Bionovate Technologies Corp (BIIO)
Bionovate Technologies Corp operates in the Medical - Devices industry of the Healthcare sector, headquartered in Cham, ZG, CH. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $775. On trailing twelve-month figures it carries a trailing P/E of -0.04, a net margin of 0.0%. Its beta of -2.51 implies it has historically moved less than the broad market.
Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body. The firm plans to distribute these advanced systems globally, marketing them to healthcare providers and wellness centers. Founded in Cham, Switzerland, in 2010, the organization previously traded under the name MJP International Ltd. before adopting Bionovate Technologies Corp. in December 2017. Since October 7, 2020, the company has operated as an affiliated entity of Human Data AG.
Bionovate Technologies Corp is most often compared with the following Healthcare names: